Hematologic Oncology Update· Staffel 26· Folge 109
Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 6
Mittwoch, 28. Oktober 2026 · 33 min
Kapitelklicken springt direkt hin
Shownotes
Featuring perspectives from Dr Lindsey Roeker, including the following topics:
• Case: A man in his mid 60s with TP53-aberrant chronic lymphocytic leukemia (CLL) with extensive marrow infiltration receives first-line venetoclax/obinutuzumab and experiences an excellent response ()
• Case: A man in his late 70s with small lymphocytic lymphoma (SLL) and cardiovascular comorbidities requiring verapamil and anticoagulation receives acalabrutinib/venetoclax; Case: A man in his early 80s with SLL receives zanubrutinib/sonrotoclax as part of the CELESTIAL-TNCLL trial ()
• Case: A man in his late 70s with progressive CLL worsening after a skiing injury receives acalabrutinib/venetoclax as part of the MAJIC trial ()
CME information and select publications (researchtopractice.com/CLLMicro2025/RapidRevie…)
